Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Meridian Bioscience Inc (NASDAQ:VIVO)

13.65
Delayed Data
As of Aug 18
 +0.05 / +0.37%
Today’s Change
10.75
Today|||52-Week Range
19.85
-22.88%
Year-to-Date

Today’s Trading

Previous close13.60
Today’s open13.50
Day’s range13.50 - 13.70
Volume224,354
Average volume (3 months)285,342
Market cap$576.1M
Dividend yield3.66%
Data as of 3:59pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)-10.59%
Earnings growth (this year)-16.25%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+0.64%
P/E ratio27.3
Price/Sales4.17
Price/Book3.45

Competitors

 Today’s
change
Today’s
% change
LNTHLantheus Holdings In...-0.25-1.55%
CALACalithera Bioscience...+0.05+0.36%
ALRPRBAlere Inc+0.71+0.18%
OXFDOxford Immunotec Glo...-0.71-4.51%
Data as of 4:00pm ET, 08/18/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)$0.14
Annual revenue (last year)$196.1M
Annual profit (last year)$32.2M
Net profit margin16.44%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
John A. Kraeutler
President &
Chief Commercial Officer
Richard L. Eberly
Corporate headquarters
Cincinnati, Ohio

Forecasts